As $Micron Technology(MU)$ hosts its live technology webinar on Wednesday, Oct. 21, 2026, at 8:00 a.m. Mountain Time, the semiconductor industry stands at a crucial juncture. This event centers on next-generation High Bandwidth Memory (HBM3e/HBM4) architectures, enterprise SSD expansion, and advanced DRAM nodes required to fuel the ongoing artificial intelligence expansion. In this article, we would like to share an analysis which demonstrates that the memory rebound is structurally differentiated from past commodity cycles. 1. Micron Webinar Preview: Core Agenda & Strategic Focus Micron Technology’s scheduled briefing on October 21, 2026, comes at a critical time for global memory markets. Management is expected to detail key technical innovati

$Micron Technology(MU)$   Micron Technology, Inc. is re-rated as a Buy, supported by strong revenue visibility, pricing power, and robust demand through FY30. CXMT’s technological advancements pose a long-term threat, but meaningful competitive impact on MU is unlikely before 2028. MU’s HBM segment is narrowing its margin gap with conventional DRAM, with higher selling prices and strong demand driving margin expansion in FY27. With a $150B backlog and 35%+ revenue covered through 2030, MU’s risk-reward profile remains attractive despite competitive and supply risks.

Memory stocks are rebounding ahead of Micron Technology’s October 21 technology webinar. Micron gained 2.97%, SanDisk climbed 5.53%, and SK Hynix rose 4.67%. The market is watching for updates on DRAM, high-bandwidth memory (HBM), NAND and the growing memory requirements of AI infrastructure. But there is a bigger question worth asking: Can memory manufacturers turn strong AI demand into lasting pricing power? AI systems need more than powerful processors. They also require fast memory to feed data to those processors and storage to retain increasingly large amounts of information. That creates opportunities across the memory industry, but the companies operate in different markets and face different competitive pressures. 🔹 $Micron Technology(MU)$ 

Memory stocks finally bounced. MU rose 2.97%, SanDisk 5.53% and SK Hynix 4.67% ahead of Micron's 21 October technology webinar. But MU is already indicated around $883 pre-market, down roughly 2.4%. So Wednesday's webinar arrives at an important moment. The market is asking whether the recent memory selloff was an overreaction, or the beginning of a genuine repricing of the cycle. My answer: HBM still looks structurally strong. Conventional memory is where I would watch the risk. 🔵 WHAT WOULD ACTUALLY MOVE MU? Micron is expected to discuss its multigenerational roadmap across DRAM, HBM and NAND, plus customer co-design and the memory requirements of next-generation AI infrastructure. I would ignore generic statements about AI demand. I want three things. 1. HBM roadmap Anything reinforcing

Memory stocks are back in the spotlight ahead of Micron Technology’s October 21 technology webinar. Micron rose 2.97%, SanDisk gained 5.53%, and SK Hynix climbed 4.67%. The gains have renewed interest in a sector benefiting from the growing demand for AI infrastructure. But the important question is whether this rally has further room to run or whether investors are getting ahead of themselves. 🔹 1. $Micron Technology(MU)$ :The HBM Opportunity High-bandwidth memory (HBM) has become an important component of advanced AI accelerators. As AI models grow more complex, the demand for faster memory and greater bandwidth continues to increase. Micron’s upcoming webinar will cover DRAM, HBM, NAND and next-generation AI infrastructure requirements. Inve

Nice sharing. Great job.

I looooooove a good webinar!!

I’d want to see positive free cash flow, sustainable margins, and real customer demand rather than just big AI spending promises. Long-term contracts and lower reliance on debt would also help rebuild confidence. Revenue growth is exciting, but profitability is what makes the model credible.

good analysis

What a difference a day makes. Earlier this week, memory looked almost uninvestable. CXMT's server DRAM expansion triggered fears that Chinese supply could weaken the scarcity economics behind the memory supercycle. MU, SNDK and SK Hynix were hammered. Then came 15 October. Buyers returned and memory stocks bounced. One green session does not make a bottom. But after such violent selling, I am asking a different question now: Has the market finally found a price where investors are willing to defend the memory thesis? I think we may be getting our first clue. 🔴 THE CXMT THREAT IS REAL, BUT THE MARKET JUMPED SEVERAL STEPS AHEAD The bearish argument effectively became: CXMT improves technology → production surges → DRAM supply rises → pricing collapses → Micron margins collapse. Possible? Ye

CXMT Targets Server Memory: Is the Memory Repricing Done? Here's What the Numbers Say, and Why I'm Not Selling Puts Yet Written Friday 16 Oct, SGT, after Thursday's US session. Last weekend in Shanghai, CXMT president Cao Kanyu said China's largest DRAM maker plans to launch a DDR5 RDIMM server module built on its new 4F² cell design by the end of 2026. A 4F² cell takes up roughly a third less area than the 6F² design the industry still uses, so you get more memory per chip. CXMT says it holds more than 300 patent families on the architecture. That's the headline. Here's what wasn't said: no speed, no capacity, no yield and no volume. It's a product launch target, not a commitment to mass production or to qualification at the big server platforms. The market didn't wait for the details. Fr

For me, the neocloud model becomes credible again when it proves cash returns, not just revenue growth and huge backlogs. I would look for high GPU utilisation, positive free cash flow after capex and interest, and contracts that remain profitable as GPUs age and rental prices fall. Customer diversification is also important because dependence on a few hyperscalers increases risk. The strongest evidence would be neoclouds funding more of their next GPU cycle from operating cash rather than repeatedly adding debt. My credibility test: utilisation → cash flow → lower leverage → diversified customers. If these improve while AI compute demand remains strong, the model deserves another look. If revenue rises but debt and capex grow even faster, the core concern remains unresolved.

I would focus on HBM rather than chase a broad memory rebound. SK Hynix still has the strongest technology and market position in HBM, while Micron may offer the more interesting catch-up story if it continues gaining HBM share and securing long-term AI orders. Micron has also said demand should exceed supply through 2027 and 2028, which suggests CXMT’s expansion may not immediately create an industry-wide glut. CXMT is a genuine longer-term threat, especially in conventional server DRAM, but advanced HBM remains much harder to replicate at scale. SanDisk and WDC could recover with strong data-centre storage demand, but that is a somewhat different AI infrastructure thesis and I would rank it behind HBM for now. My preference: SK Hynix technology lead > Micron HBM share gains > SanDi

I see this as a valuation reset rather than the end of the AI story. AI demand remains strong, but investors are becoming more selective about capital spending, financing costs and cash flow. Growth alone is no longer enough when valuations are stretched. Personally, I would consider healthcare and consumer staples for diversification, as their earnings tend to be more resilient. However, I would not chase defensive stocks simply because they are outperforming. Valuation and cash flow still matter, especially in a higher-for-longer interest rate environment. For my portfolio, I prefer to stay disciplined rather than react to short-term rotations. I will monitor Treasury yields, earnings and technical levels while continuing to accumulate quality companies patiently on pullbacks. Consisten

① Healthcare — stable demand and predictable earnings. I favor healthcare, not because AI has lost its future, but because investors are reassessing distant growth. Sticky inflation and higher Treasury yields pressure businesses requiring massive capital spending before generating cash flow. Healthcare companies benefit from resilient demand and relatively stable earnings. However, defensive stocks are not automatically bargains. Patent expirations, regulatory pressure and excessive valuations can still destroy returns. The market is repricing earnings certainty. AI may continue transforming the economy, but investors are becoming less willing to pay any price for growth. My strategy: favor fairly valued healthcare companies with durable cash flows. When uncertainty rises, investors should

Nice Sharing 😁 leaning more towards health care [Smile]. @Barcode @Shyon @koolgal @JC888 @DiAngel @Aqa @Shernice軒嬣 2000

$MU$   Micron Technology is stuck in a spiral amid concerns about Chinese competition and the artificial-intelligence trade in general. But shareholder returns could help it rebound, according to analysts. Micron shares were down 4.4% at $873.70 in premarket trading. A slide that began at the start of the week on news that China's CXMT was developing a new memory chip has been compounded by fears about the wider AI trade. South Korean memory companies Samsung Electronics and SK Hynix were even harder hit, dropping 9.5% and 11%, respectively, in local trading on Thursday. But the worries are overblown, according to UBS analyst Nicolas Gaudois. He notes that CXMT's so-called 4F square des